Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 5, 2000, Pages 523-527

  Hawk, Ernest ^a   Breslow, Rosalind A ^a   Graubard, Barry I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADULT; AGED; AGING; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; DEATH CERTIFICATE; FOLLOW UP; HEALTH SURVEY; HORMONE ACTION; HUMAN; INTERVIEW; MALE; MALE TYPE ALOPECIA; MEDICAL RECORD; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGING; ALOPECIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 0034065417     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
2. Guileyardo, J. M., Johnson, W. D., Welsh, R. A., Akazaki, K., and Correa, P. Prevalence of latent prostate carcinoma in two U. S. populations. J. Natl. Cancer Inst., 65: 311-316, 1980.
3. Sakr, W. A., Haas, G. P., and Cassin, B. F. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young males. J. Urol., 150: 379-385, 1997.
4. Norwood, O. T. Male pattern baldness: classification and incidence. South. Med. J., 68: 1359-1365, 1975.
5. Hamilton, J. B. Patterned loss of hair in man: types and incidence. Ann. NY Acad. Sci., 53: 708-728, 1950.
6. SEER cancer statistics review, 1973-1994. In: L. A. Ries, C. L. Kosary, B. F. Hankey, B. A. Miller, A. Harras, and B. K. Edwards (eds.), NIH Publ. No. 97-2789. Bethesda, MD: National Cancer Institute, 1997.
7. Randall, V. A. Androgens and human hair growth. Clin. Endocrinol., 40: 439-457, 1994.
8. Olsen, E. A. Androgenetic alopecia. In: E. A. Olsen (ed.). Disorders of Hair Growth - Diagnosis and Treatment, pp. 257-283. New York: McGraw-Hill, Inc., 1994.
9. Giovannucci, E. Epidemiologic characteristics of prostate cancer. Cancer (Phila.), 75: 1766-1777, 1995.
10. Haas, G. P., and Sakr, W. A. Epidemiology of prostate cancer. CA Cancer J. Clin., 47: 273-287, 1997.
11. Miller, N. W. National Center for Health Statistics. Plan and Operation of the Health and Nutrition Examination Survey. United States, 1971-1973. Vital and Health Statistics, Series 1 (10a). Washington DC: United States Government Printing Office, 1973.
12. National Center for Health Statistics. Plan and Operation of the Health and Nutrition Examination Survey, United States, 1971-1973. Vital and Health Statistics, Series 1 (10b). Washington DC: United States Government Printing Office, 1977.
13. Engel, A., Murphy, R. S., Maurer, K., and Collins, E. National Center for Health Statistics. Plan and Operation of the HANES I Augmentation Survey of Adults 25-74 Years, United States, 1974-1975. Vital and Health Statistics, Series 1 (14). Washington DC: United States Government Printing Office, 1978.
14. Cox, C. S., Mussolino, M. E., Rothwell, S. T., Lane, M. A., Golden, C. D., Madans, J. H., and Feldman, J. J. Plan and Operation of the NHANES I Epidemiologic Follow-up Study 1992. National Center for Health Statistics. Vital and Health Statistics. Series 1 (35). Washington DC: United States Government Printing Office, 1997.
15. Johnson, M. T., and Roberts, J. Skin Conditions and Related Need for Medical Care among Persons 1-74 Years, United States, 1971-1974, Ed. 11, No. 212, pp. 1-26. Hyaltsville, MD: United States Department of Health, Education, and Welfare, 1978.
16. Ford, E. S., Freedman, D. S., and Byers, T. Baldness and ischemic heart disease in a national sample of men. Am. J. Epidemiol., 143: 651-657, 1996.
17. Breslow, R. A., Wideroff, L., Graubard, B. I., Erwin, D., Reichman, M. E., Ziegler, R. G., and Ballard-Barbash, R. Alcohol and prostate cancer in the NHANES I Epidemiologic Follow-up Study. Ann. Epidemiol., 9: 254-261, 1999.
18. Breslow, N. E., and Day, N. E. The Design and Analysis of Cohort Studies. Lyons, France: IARC, 1987.
19. Korn, E. L., Graubard, B. I., and Midthune, D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am. J. Epidemiol., 145: 72-80, 1997.
20. Korn, E. L., and Graubard, B. I. Analysis of large health surveys: accounting for the sample design. J. R. Stat. Soc., 158: 263-295, 1995.
21. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., and Walsh, P. C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797-802, 1993.
22. Wynder, E. L., Mabuchi, K., and Whitmore, W. F., Jr. Epidemiology of cancer of the prostate. Cancer (Phila.), 28: 344-360, 1971.
23. Greenwald, P., Damon, A., Kirmss, V., and Polan, A. K. Physical and demographic features of men before developing cancer of the prostate. J. Natl. Cancer Inst., 53: 341-346, 1974.
24. Oishi, K., Okada, K., Yoshida, O., Yamabe, H., Ohno, Y., Hayes, R. B., Schroeder, F. H., and Boyle, P. Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors. Prostate, 14: 117-122, 1989.
25. Demark-Wahnefried, W., Lesko, S. M., Conaway, M. R., Robertson, C. N., Clark, R. V., Lobaugh, B., Mathias, B. J., Strigo, T. S., and Paulson, D. F. Serum androgens: associations with prostate cancer risk and hair patterning. J. Androl., 18: 495-500, 1997.
26. Hsieh, C. C., Thanos, A., Mitropoulos, D., Deliveliotis, C., Mantzoros, C. S., and Trichopoulos, D. Risk factors for prostate cancer: a case-control study in Greece. Int. J. Cancer, 80: 699-703, 1999.
27. Herrera, C. R., D'Agostino, R. B., Gerstman, B. B., Bosco, L. A., and Belanger, A. J. Baldness and coronary heart disease rates in men from the Framingham Study. Am. J. Epidemiol., 142: 828-833, 1995.
28. Lesko, S. M., Rosenberg, L., and Shapiro, S. A case-control study of baldness in relation to myocardial infarction in men. J. Am. Med. Assoc., 269: 998-1003, 1993.
29. Isaacs, J. T. Role of androgens in prostatic cancer. Vitam. Horm., 49: 433-502, 1994.
30. Wilding, G. Endocrine control of prostate cancer. Cancer Surv., 23: 43-62, 1995.
31. Luu-The, V., Sugimoto, Y., Puy, L., Labrie, Y., Lopez-Solache, I., Singh, M., and Labrie, F. Characterization, expression, and immunohistochemical localization of 5 α-reductase in human skin. J. Investig. Dermatol., 102: 221-226, 1994.
32. Harris, G., Azzolina, B., Baginsky, W., Cimis, G., Rasmusson, G. H., Tolman, R. L., Raetz, C. R., and Ellsworth, K. Identification and selective inhibition of an isozyme of steroid 5 α-reductase in human scalp. Proc. Natl. Acad. Sci. USA, 89: 10787-10791, 1992.
33. Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., and Russell, D. W. Tissue distribution and ontogeny of steroid 5 α-reductase 7 isozyme expression. J. Clin. Investig., 92: 903-910, 1993.
34. Patel, S., Einstein, M., Geissler, W., Wu, L., and Andersson, S. Immunohistochemical analysis of steroid 5 α-reductase type 1 in human scalp and prostate. Ann. NY Acad. Sci., 784: 27-39, 1996.
35. Puerto, A. M., and Mallol, J. Regional scalp differences of the androgenic metabolic pattern in subjects affected by male pattern baldness. Rev. Esp. Fisiol., 46: 289-296, 1990.
36. Bruchovsky, N., Rennie, P. S., Batzold, F. H., Goldenberg, S. L., Fletcher, T., and McLoughlin, M. G. Kinetic parameters of 5 α-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J. Clin. Endocrinol. Metab., 67: 806-816, 1988.
37. Rittmaster, R. S. Finasteride, N. Engl. J. Med., 330: 120-125, 1994.
38. Castro-Magana, M., Angulo, M., Fuentes, B., Canas, A., Sarrantonio, M., Arguello, R., and Vitollo, P. Effect of finasteride on human testicular steroidogenesis. J. Androl., 17: 516-521, 1996.
39. Dallob, A. L., Sadick, N. S., Unger, W., Dallob, A. L., Sadick, N. S., Unger, W., Lipert, S., Geissler, L. A., Gregoire, S. L., Nguyen, H. H., Moore, E. C., and Tanaka, W. K. The effect of finasteride, a 5 α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J. Clin. Endocrinol. Metab., 79: 703-706, 1994.
40. Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfield, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., Shapiro, J., Binkowitz, B., and Gormley, G. J. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J. Am. Assoc. Dermatol., 39: 578-589, 1998.
41. Feigl, P., Blumenstein, B., Thompson I., Crowley, J., Wolf, M., Kramer, B. S., Coltman, C. A., Jr., Brawley, O. W., and Ford, L. G. Design of the Prostate Cancer Prevention Trial (PCPT). Control Clin. Trials, 16: 150-163, 1995.